PMID- 23023090 OWN - NLM STAT- MEDLINE DCOM- 20130411 LR - 20210103 IS - 1872-7905 (Electronic) IS - 0022-1759 (Linking) VI - 387 IP - 1-2 DP - 2013 Jan 31 TI - A novel assay for detecting virus-specific antibodies triggering activation of Fcgamma receptors. PG - 21-35 LID - S0022-1759(12)00288-8 [pii] LID - 10.1016/j.jim.2012.09.006 [doi] AB - IgG responses are crucial in antiviral defence and instrumental for the serodiagnosis of infections. Fcgamma receptors (FcgammaRs), which recognize the Fc-part of IgG, differ regarding their IgG binding affinity, IgG subclass preference, cellular expression profile and pathogen elimination mechanisms elicited upon activation. Assessing their activation in vitro is of fundamental importance, but technically difficult. Therefore, a novel assay for measuring antiviral IgG antibodies triggering activation of individual host Fcgamma receptors was established. The assay comprises the co-cultivation of virus-infected target cells with immune IgG antibodies and mouse BW5147 hybridoma cells stably expressing chimeric FcgammaR-CD3zeta chain molecules consisting of the extracellular domain of human FcgammaRIIIA, FcgammaRIIA or FcgammaRI, respectively, fused to the transmembrane and intracellular domains of the mouse CD3zeta chain. Triggering of the chimeric FcgammaR receptors by immune complexes formed on the surface of IgG-opsonized virus-infected target cells resulted in FcgammaR activation leading to IL-2 secretion by BW5147 cells, which was quantified as a surrogate marker in an ELISA. Target cells infected with various human pathogenic viruses including herpes simplex virus type 1 (HSV-1), Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), measles virus (MV), and respiratory syncytial virus (RSV) or displaying human immunodeficiency virus-1 (HIV-1) gp120 evoke dose-dependent IgG responses demonstrating the universal applicability of the assay. Taken together, a new reliable and simple tool for measuring antibodies triggering activation of Fcgamma receptors was established. This assay will be instrumental for defining novel correlates of IgG immunity and the design of new therapeutic IgGs. CI - Copyright (c) 2012 Elsevier B.V. All rights reserved. FAU - Corrales-Aguilar, Eugenia AU - Corrales-Aguilar E AD - Institute for Virology, Heinrich-Heine-University Dusseldorf, Universitatsstrasse 1, 40225 Dusseldorf, Germany. FAU - Trilling, Mirko AU - Trilling M FAU - Reinhard, Henrike AU - Reinhard H FAU - Merce-Maldonado, Eva AU - Merce-Maldonado E FAU - Widera, Marek AU - Widera M FAU - Schaal, Heiner AU - Schaal H FAU - Zimmermann, Albert AU - Zimmermann A FAU - Mandelboim, Ofer AU - Mandelboim O FAU - Hengel, Hartmut AU - Hengel H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120927 PL - Netherlands TA - J Immunol Methods JT - Journal of immunological methods JID - 1305440 RN - 0 (Antibodies, Viral) RN - 0 (CD3 Complex) RN - 0 (CD3 antigen, zeta chain) RN - 0 (Immunoglobulin G) RN - 0 (Interleukin-2) RN - 0 (Receptors, IgG) RN - 0 (Recombinant Fusion Proteins) SB - IM MH - Animals MH - Antibodies, Viral/*immunology/metabolism MH - CD3 Complex/genetics/immunology/metabolism MH - Cell Line MH - Cell Line, Transformed MH - Cell Line, Tumor MH - Chlorocebus aethiops MH - Coculture Techniques MH - Cytomegalovirus/immunology MH - Enzyme-Linked Immunosorbent Assay/*methods MH - HEK293 Cells MH - Herpesvirus 1, Human/immunology MH - Herpesvirus 4, Human/immunology MH - Humans MH - Hybridomas MH - Immunoglobulin G/immunology/metabolism MH - Interleukin-2/immunology/metabolism/pharmacology MH - Killer Cells, Natural/drug effects/immunology/metabolism MH - Mice MH - Protein Binding/immunology MH - Receptors, IgG/genetics/*immunology/metabolism MH - Recombinant Fusion Proteins/genetics/immunology/metabolism MH - U937 Cells MH - Vero Cells MH - Viruses/*immunology EDAT- 2012/10/02 06:00 MHDA- 2013/04/12 06:00 CRDT- 2012/10/02 06:00 PHST- 2012/06/10 00:00 [received] PHST- 2012/08/12 00:00 [revised] PHST- 2012/09/19 00:00 [accepted] PHST- 2012/10/02 06:00 [entrez] PHST- 2012/10/02 06:00 [pubmed] PHST- 2013/04/12 06:00 [medline] AID - S0022-1759(12)00288-8 [pii] AID - 10.1016/j.jim.2012.09.006 [doi] PST - ppublish SO - J Immunol Methods. 2013 Jan 31;387(1-2):21-35. doi: 10.1016/j.jim.2012.09.006. Epub 2012 Sep 27.